
|Articles|August 1, 1999
The American Journal of Managed Care
- August 1999
- Volume 5
- Issue 8
A Short-Term Cost-of-Treatment Model for Type 2 Diabetes: Comparison of Glipizide Gastrointestinal Therapeutic System, Metformin, and Acarbose
Advertisement
Articles in this issue
over 26 years ago
A Model for Improving Coverage Policy Decisionsover 26 years ago
The Impact of Relational Activities on HMO Organizational Outcomesover 26 years ago
HIV Infection in Adults: A Therapeutic Updateover 26 years ago
To Cover or Not to Cover: How to Decide?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
2
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
3
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
4
52-Week VERIFY Data Show Rusfertide Brings Sustained Responses in PV
5














































